Quadrant Capital Group’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-4,916
| Closed | -$484K | – | 2675 |
|
|
2025
Q2 | $484K | Buy |
4,916
+184
| +4% | +$17.4K | 0.02% | 893 |
|
|
2025
Q1 | $438K | Buy |
4,732
+4,030
| +574% | +$372K | 0.02% | 833 |
|
|
2024
Q4 | $63.7K | Buy |
702
+51
| +8% | +$4.68K | ﹤0.01% | 1284 |
|
|
2024
Q3 | $62.8K | Sell |
651
-81
| -11% | -$7.9K | ﹤0.01% | 1329 |
|
|
2024
Q2 | $67.2K | Buy |
732
+115
| +19% | +$10.7K | 0.01% | 1245 |
|
|
2024
Q1 | $56.9K | Sell |
617
-29
| -4% | -$2.72K | ﹤0.01% | 1320 |
|
|
2023
Q4 | $61.4K | Sell |
646
-40
| -6% | -$3.74K | 0.01% | 1272 |
|
|
2023
Q3 | $64.1K | Buy |
686
+32
| +5% | +$2.96K | 0.01% | 1119 |
|
|
2023
Q2 | $59.8K | Buy |
654
+42
| +7% | +$3.45K | 0.01% | 1163 |
|
|
2023
Q1 | $45K | Buy |
612
+315
| +106% | +$27.3K | ﹤0.01% | 1292 |
|
|
2022
Q4 | $24.8K | Buy |
297
+51
| +21% | +$4.6K | ﹤0.01% | 1553 |
|
|
2022
Q3 | $24K | Buy |
246
+189
| +332% | +$22.5K | ﹤0.01% | 1444 |
|
|
2022
Q2 | $6K | Buy |
57
+6
| +12% | +$767 | ﹤0.01% | 1877 |
|
|
2022
Q1 | $8K | Buy |
51
+6
| +13% | +$896 | ﹤0.01% | 1726 |
|
|
2021
Q4 | $7K | Sell |
45
-29
| -39% | -$4.66K | ﹤0.01% | 1754 |
|
|
2021
Q3 | $11K | Sell |
74
-81
| -52% | -$16.8K | ﹤0.01% | 1515 |
|
|
2021
Q2 | $38K | Sell |
155
-4
| -3% | -$1.05K | 0.01% | 948 |
|
|
2021
Q1 | $42K | Buy |
159
+18
| +13% | +$5.08K | 0.01% | 881 |
|
|
2020
Q4 | $41K | Sell |
141
-11
| -7% | -$2.82K | 0.01% | 810 |
|
|
2020
Q3 | $36K | Sell |
152
-462
| -75% | -$105K | 0.01% | 754 |
|
|
2020
Q2 | $122K | Buy |
614
+465
| +312% | +$86.7K | 0.03% | 391 |
|
|
2020
Q1 | $27K | Sell |
149
-91
| -38% | -$16.2K | ﹤0.01% | 1150 |
|
|
2019
Q4 | $40K | Buy |
+240
| New | +$35.7K | ﹤0.01% | 1443 |
|
|
2019
Q2 | – | Sell |
-49
| Closed | -$6K | – | 2309 |
|
|
2019
Q1 | $6K | Buy |
+49
| New | +$6.15K | ﹤0.01% | 1811 |
|
|
2016
Q4 | – | Sell |
-18
| Closed | – | – | 1987 |
|
|
2016
Q3 | $0 | Sell |
18
-23
| -56% | -$1.15K | ﹤0.01% | 1988 |
|
|
2016
Q2 | $1K | Buy |
+41
| New | +$2.07K | ﹤0.01% | 1570 |
|
Other funds holding AMED
IA
MCI
HNB
Quadrant Capital Group's AMED Position: Q3 2025 in Review
Quadrant Capital Group sold out of Amedisys (AMED) in Q3 2025, closing a stake of 4,916 shares — an estimated $484K sold.
Quadrant Capital Group first reported a position in AMED in Q2 2016 and held it in 26 quarters. The position peaked at $484K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Quadrant Capital Group reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Quadrant Capital Group sold 4,916 Amedisys shares in Q3 2025, an estimated $484K.
- Quadrant Capital Group first reported a position in Amedisys in Q2 2016 and held it in 26 quarters.
- Quadrant Capital Group's Amedisys position peaked at $484K in Q2 2025.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Quadrant Capital Group's 13F filing for Q3 2025, filed 13 Nov 2025.